KAIROS PHARMA LTD

KAPANYSE AMERICAN

🏆 #4473 by market capUS Equity

$0.36▼ $0.00 (−1.05%)

Live

1h▲ 1.6%

24h▼ 1.1%

7d▲ 10.6%

14d▲ 30.7%

30d▲ 6.5%

1y▼ 68.0%

🏦Market Cap

$8M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

46

Weak

Earnings

Q2 · 2026Reported 2026-05-13

Earnings Per Share

Actual

-0.08

Expected

-0.07

miss

−14.30%

YoY +0.00%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q2 2026

-0.08

miss

Q1 2026

-0.07

miss

Q4 2025

-0.07

beat

Q3 2025

-0.08

miss